However, more recent studies show that tau burden patterns exhibit notable heterogeneity across individuals with AD, often diverging from the stereotypical Braak staging system (Ferreira et al., 2020; Vogel et al., 2021; Young et al., 2022). This evidence concerns the gene MAPT and Alzheimer disease.